Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Senseonics
company
About
Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems.
- 51 - 100
Highlights
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $41M
- Industries
- Biotechnology,Health Care,Medical,Medical Device,Sensor,Wearables
- Founded date
- Jan 1, 1996
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Senseonics is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that is intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$41M
Senseonics has raised a total of
$41M
in funding over 2 rounds. Their latest funding was raised on
May 31, 2017 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 31, 2017 | Post-IPO Equity | $41M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Senseonics is funded by 1 investors.
Roche Finance
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Post-IPO Equity |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
